239 related articles for article (PubMed ID: 24465134)
1. Microvascular pericytes in healthy and diseased kidneys.
Pan SY; Chang YT; Lin SL
Int J Nephrol Renovasc Dis; 2014 Jan; 7():39-48. PubMed ID: 24465134
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of fibrosis: the role of the pericyte.
Schrimpf C; Duffield JS
Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.
Campanholle G; Ligresti G; Gharib SA; Duffield JS
Am J Physiol Cell Physiol; 2013 Apr; 304(7):C591-603. PubMed ID: 23325411
[TBL] [Abstract][Full Text] [Related]
5. Pivotal role of pericytes in kidney fibrosis.
Kida Y; Duffield JS
Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):467-73. PubMed ID: 21517936
[TBL] [Abstract][Full Text] [Related]
6. Update of pericytes function and their roles in kidney diseases.
Chou YH; Pan SY; Shih HM; Lin SL
J Formos Med Assoc; 2024 Mar; 123(3):307-317. PubMed ID: 37586973
[TBL] [Abstract][Full Text] [Related]
7. Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling.
Castellano G; Franzin R; Stasi A; Divella C; Sallustio F; Pontrelli P; Lucarelli G; Battaglia M; Staffieri F; Crovace A; Stallone G; Seelen M; Daha MR; Grandaliano G; Gesualdo L
Front Immunol; 2018; 9():1002. PubMed ID: 29875766
[TBL] [Abstract][Full Text] [Related]
8. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.
Ren S; Johnson BG; Kida Y; Ip C; Davidson KC; Lin SL; Kobayashi A; Lang RA; Hadjantonakis AK; Moon RT; Duffield JS
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1440-5. PubMed ID: 23302695
[TBL] [Abstract][Full Text] [Related]
9. Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients.
Nasri H
Cell J; 2014; 15(4):378-80. PubMed ID: 24381864
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase inhibitor ameliorates senescent changes of renal interstitial pericytes in aging kidney.
Kim HD; Kim EN; Lim JH; Kim Y; Ban TH; Lee H; Kim YS; Park CW; Choi BS
Aging Cell; 2024 Mar; 23(3):e14075. PubMed ID: 38155524
[TBL] [Abstract][Full Text] [Related]
11. The role played by perivascular cells in kidney interstitial injury.
Rojas A; Chang FC; Lin SL; Duffield JS
Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886
[TBL] [Abstract][Full Text] [Related]
12. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction.
Fligny C; Duffield JS
Curr Opin Rheumatol; 2013 Jan; 25(1):78-86. PubMed ID: 23196325
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
[TBL] [Abstract][Full Text] [Related]
14. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.
Lin SL; Chang FC; Schrimpf C; Chen YT; Wu CF; Wu VC; Chiang WC; Kuhnert F; Kuo CJ; Chen YM; Wu KD; Tsai TJ; Duffield JS
Am J Pathol; 2011 Feb; 178(2):911-23. PubMed ID: 21281822
[TBL] [Abstract][Full Text] [Related]
15. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.
Schrimpf C; Xin C; Campanholle G; Gill SE; Stallcup W; Lin SL; Davis GE; Gharib SA; Humphreys BD; Duffield JS
J Am Soc Nephrol; 2012 May; 23(5):868-83. PubMed ID: 22383695
[TBL] [Abstract][Full Text] [Related]
16. Exogenous bone marrow derived-putative endothelial progenitor cells attenuate ischemia reperfusion-induced vascular injury and renal fibrosis in mice dependent on pericytes.
Wang M; Xu H; Li Y; Cao C; Zhu H; Wang Y; Zhao Z; Pei G; Zhu F; Yang Q; Deng X; Zhou C; Guo Y; Wu J; Liao W; Yang J; Yao Y; Zeng R
Theranostics; 2020; 10(26):12144-12157. PubMed ID: 33204334
[No Abstract] [Full Text] [Related]
17. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.
Humphreys BD; Lin SL; Kobayashi A; Hudson TE; Nowlin BT; Bonventre JV; Valerius MT; McMahon AP; Duffield JS
Am J Pathol; 2010 Jan; 176(1):85-97. PubMed ID: 20008127
[TBL] [Abstract][Full Text] [Related]
18. Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy.
Humphreys BD
Semin Nephrol; 2012 Sep; 32(5):463-70. PubMed ID: 23062987
[TBL] [Abstract][Full Text] [Related]
19. Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.
Yang J; Wang M; Zhu F; Sun J; Xu H; Chong Lee Shin OL; Zhao Z; Pei G; Zhu H; Cao C; He X; Huang Y; Ma Z; Liu L; Wang L; Ning Y; Liu W; Xu G; Wang X; Zeng R; Yao Y
Stem Cell Res Ther; 2019 Mar; 10(1):104. PubMed ID: 30898157
[TBL] [Abstract][Full Text] [Related]
20. The role of pericyte detachment in vascular rarefaction.
Schrimpf C; Teebken OE; Wilhelmi M; Duffield JS
J Vasc Res; 2014; 51(4):247-58. PubMed ID: 25195856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]